Objectives: The aim of this study was to investigate the protective effects of a sustained release form of dexamethasone (dex) loaded chitosan-based genipin-cross-linked hydrogel (CBGCH) in a guinea pig model of cisplatin (CP) induced hearing loss
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
OBJECTIVE: To investigate the possible protective effects of alpha-tocopherol and tiopronin again...
Cisplatin (cisdiaminodichloroplatinum) (CDDP) is a chemotherapeutic agent often used in the treatmen...
Objectives: The aim of this study was to investigate the protective effects of a sustained release f...
OBJECTIVE: The purpose of this study was to investigate the effectiveness of intratympanic dexametha...
Background: Middle ear (intratympanic, IT) administration is a promising therapeutic method as it of...
OBJECTIVE:Cisplatin is a chemotherapeutic drug known to induce hearing loss. Although corticosteroid...
Changling Sun,1,3,* Xueling Wang,1,* Zhaozhu Zheng,2 Dongye Chen,1 Xiaoqin Wang,2 Fuxin Shi,1 Dehong...
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this...
The purpose of this study was to investigate the effectiveness of intratympanic dexamethasone inject...
Introduction: Cisplatin chemotherapy causes ototoxicity manifested as sensorineural hearing loss and...
The otoprotective effects of OTO-104 were investigated following both acute and chronic administrati...
In mammals, inner hair cells have lost their regenerative abilities. Thus, when they are damaged, ac...
Abstract Purpose: To evaluate the ability of dexamethasone to protect against cisplatin (CDDP)-ind...
Objective: To evaluate Cisplatin (CP) induced ototoxicity and the effects of vitamin B treatment on ...
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
OBJECTIVE: To investigate the possible protective effects of alpha-tocopherol and tiopronin again...
Cisplatin (cisdiaminodichloroplatinum) (CDDP) is a chemotherapeutic agent often used in the treatmen...
Objectives: The aim of this study was to investigate the protective effects of a sustained release f...
OBJECTIVE: The purpose of this study was to investigate the effectiveness of intratympanic dexametha...
Background: Middle ear (intratympanic, IT) administration is a promising therapeutic method as it of...
OBJECTIVE:Cisplatin is a chemotherapeutic drug known to induce hearing loss. Although corticosteroid...
Changling Sun,1,3,* Xueling Wang,1,* Zhaozhu Zheng,2 Dongye Chen,1 Xiaoqin Wang,2 Fuxin Shi,1 Dehong...
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this...
The purpose of this study was to investigate the effectiveness of intratympanic dexamethasone inject...
Introduction: Cisplatin chemotherapy causes ototoxicity manifested as sensorineural hearing loss and...
The otoprotective effects of OTO-104 were investigated following both acute and chronic administrati...
In mammals, inner hair cells have lost their regenerative abilities. Thus, when they are damaged, ac...
Abstract Purpose: To evaluate the ability of dexamethasone to protect against cisplatin (CDDP)-ind...
Objective: To evaluate Cisplatin (CP) induced ototoxicity and the effects of vitamin B treatment on ...
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
OBJECTIVE: To investigate the possible protective effects of alpha-tocopherol and tiopronin again...
Cisplatin (cisdiaminodichloroplatinum) (CDDP) is a chemotherapeutic agent often used in the treatmen...